Find news and press releases on SHRO discoveries, events, and other significant announcements. |
PRESS RELEASES: 2011- 2005 SHRO RELEASE 2011 New Adiponectin Compound Developed November 14, 2011 A compound that mimics the effects of adiponectin, a beneficial protein that is produced by fat tissue in healthy weight individuals and may exhibit protective effects against cancer, cardiovascular disease, inflammatory conditions and insulin resistance has been developed by an international consortium lead by Dr. Eva Surmacz, Associate Professor in Biology (Adjunct) and director of the Obesity and Cancer Program at the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University’s College of Science and Technology. New Frontiers: An International Workshop Examining the Latest Research in Cancer Prevention November 2, 2011 November 2 special public policy medical conference New Frontiers: An International Workshop Examining the Latest Research in Cancer Prevention sponsored by the Sbarro Health Research Organization and the National Italian American Foundation, was held on October 28th during the NIAF 36th Anniversary Gala Convention. FDA Delays Approval of New Diabetes Drug October 27, 2011 The Food and Drug Administration announced that they are pushing back its decision date to approve dapagliflozen, an experimental once-a-day drug to treat adults with Type 2 diabetes from AstraZeneca and Bristol-Myers Squibb, Bloomberg Business Week reports. Second Annual Giovan Giacomo Giordano Award for Ethics and Creativity in Medical Research October 29, 2011 Dr. George Katter, a cardiologist who has dedicated a large part of his career to serving the sick and the poor Western Pennsylvania and in Haiti, will receive the second annual Giovan Giacomo Giordano Foundation and the National Italian American Foundation Award for Ethics and Creativity in Medical Research. Dr. Katter will be recognized at the National Italian American Foundations' 36th Anniversary Awards Convention Weekend, held October 28-29 at the Washington Hilton in Washington, D.C. Dr. Antonio Giordano, NIAF board member and President and Founder of the Sbarro Health Research Organization, will present the award. SHRO Featured in Seminar on U.S. & Italian Strategies for Turning Academic Research into Business October 5, 2011 The Sbarro Health Research Organization will be featured in a U.S. and Italian Research Start Up Showcase during U.S. & Italian Strategies for Turning Academic Research into Business -- An Italian Trade Commission International Seminar to Support U.S. -Italy Technology Transfer. The seminar will be held at the Cambridge Innovation Center on October 13-14th. Dr. Giuseppe Russo, research assistant professor and Director, Cancer Systems Biology and e-Health Programs for SHRO, will present SHRO as a case study of a successful international start up. October 3, 2011 Cancer costs are rising at such a rapid rate that they threaten to become unsustainable even for rich countries, according to an expert panel assembled the The Lancet Oncology medical journal and reported by Bloomberg News. Congress to Focus on Body, Mind and Health September 27, 2011 Sbarro Health Research Organization and the Philadelphia and Delaware Valley branch of the Dominican Medical Collegiate will sponsor the 11th Dominican-American Medical Congress on the theme of Body, Mind and Health on September 30-October 2 at the Holiday Inn Hotel in Breinigsville, PA. The event will include a gala dinner and tours to historical sites in the Allentown area. For more information, call 215-291-9392 or 215-229-4357 or go to www.congreso.cmdfd.org. Study Suggests Higher Cancer Risk for 9/11 Firefighters September 10, 2011 A new study shows that firefighters who worked in the wreckage of the World Trade Center were 19 percent more likely to develop cancer than those who were not there, reports the New York Times. The study, which is the strongest evidence to date of a possible link between work at ground zero and cancer, was published in The Lancet. September 1, 2011 Grad student David Mangani Rizzo defines Systems Biology Vatican Archbishop Visits Sbarro Health Research Organization August 11, 2011 Sbarro Health Research Organization Biotechnology Research Center welcomed Archbishop Zygmunt Zimowki, the president for the Pontifical Council for Pastoral Care of Health Care Workers for the Catholic Church at the Vatican. Monsignor Zimowki is in charge of the church's global outreach for equitable health care. New Avenues Open Up for Mesothelioma Therapies July 25, 2011 Researchers from the lab of Antonio Giordano, M.D., Ph.D., the Founder and Director of the Sbarro Institute for Cancer Research and Molecular Medicine, have identified new potential anti-tumor agents that might be effective in treating mesothelioma, one of the deadliest cancer tumors. Results appear in the journal Oncogene. Salerno, Italy Honors Dr. Giordano July 25, 2011 Congratulations to Antonio Giordano, M.D., PhD, the Director of the Sbarro Health Institute for Cancer Research and Molecular Medicine in Philadelphia, who on July 23rd received the prestigious Premio Salernitani illustri nel mondo prize for his professional contributions. The award was presented at the Palace St. Augustine in Salerno, Italy Toxic Waste Dumps in Campania Region Exacts High Toll on Residents' Health July 7, 2011 A new report from the Sbarro Institute and the Human Health Foundation shows mounting scientific evidence that supports a significant increase in cancer mortality and malformations in specific areas of the Campania Region of Southern Italy, where improper waste management and illegal waste trafficking have been repeatedly documented. The study, Wasting lives: the effects of toxic waste exposure on health. The case of Campania, Southern Italy , was published in Cancer Biology & Therapy. Dangers of Non-Filtered Cigarettes June 27, 2011 While many young people mistakenly believe that hand-rolled cigarettes are less dangerous to smoke than filtered cigarettes, a new study shows that smoking hand-rolled cigarettes has stronger genotoxic and oxidative effects on the metabolism than smoking manufactured filtered-cigarettes. Entering the "Genomic Era" in Cancer Care June 27, 2011 Cancer treatment is on the brink of a new era of genome based treatment, according to Dr. George Sledge, the outgoing president of ASCO. And the Sbarro Health Research Organization for Biotechnology Research is on the cutting edge of this revolution in genomic therapies. Important New Skin Cancer Drug Approved June 16, 2011 Michele Maio, a member of the scientific board of the Sbarro Health Research Organization (SHRO) and director of the Center for Cancer Immunotherapy of Siena, in collaboration with researchers from Human Health Onlus Foundation (HHF) of Spoleto, led the project Nibit M1, using for the first time Ipilimumab in combination with a chemotherapeutic agent (fotemustine) to combat cancer. Ipilimumab has recently been approved by the FDA for the treatment of skin cancer. Life Sciences Cited as Economic Driver May 27, 2011 University City Science Center President & CEO Stephen S. Tang, Ph.D., MBA, highlighted the importance of the life sciences as an economic driver as he testified at a hearing of the U.S. Congress Joint Economic Committee on Wednesday, May 25, 2011 in Washington, DC. Current Clinical Pathology May 17, 2011 Humana Press link for Current Clinical Pathology Series, edited by Antonio Giordano, M.D., Ph.D. This series includes monographs dealing with important topics in surgical pathology, cytopathology hematology, and diagnostic laboratory medicine. It is aimed at practicing hospital based pathologists and their residents providing them with concise up-to- date reviews and state of the art summaries of current problems that these physicians may encounter in their daily practice of clinical pathology. May 2, 2011 New long lasting insulin degludec may cut down on doses for Type-2 diabetics. Rep. Critz Tours SHRO Research Facility April 19, 2011 United States Congressman Mark S. Critz (D-PA) visited the Sbarro Health Research Organization for Biotechnology at the College of Science and Technology on the campus of Temple University. Expressing his strong support for funding biotechnology research, Rep. Critz toured the newly renovated SHRO facility with Dr. Antonio Giordano, the President and Founder of SHRO and the Director of the Sbarro Institute for Cancer Research and Molecular Medicine and Dr. Hai-Lung Dai, the Dean of the College of Science and Technology. Study Highlights Cancer Fighting Properties of Good Nutrition April 19, 2011 A new study sponsored by the Human Health Foundation and led by Umberto Galderisi, Associate Professor at the Department of Experimental Medicine, Second University of Naples and an adjunct professor at the Sbarro Institute in Philadelphia, USA, highlights the quality of certain vegetables, especially broccoli, in preserving the 'vitality' of stem cells. Clinical trial success for Crohn's disease cell therapy April 13, 2011 Professor Miguel Forte described research into a new cell therapy for chronic inflammatory conditions such as Crohn's disease. Patient's own blood cells are used to produce a type of cell, Type 1 T regulatory lymphocyte,that can reduce the extent of the disease. Antonio Giordano, M.D., Ph.D. Named to NIAF Board March 28, 2011 President and Founder of S.H.R.O is one of seven prestigious Italian-Americans, who have excelled in the fields of communication, business and medicine, to be elected to the Board of Directors of the National Italian American Foundation (NIAF). A Miserable Life May Lead to Longevity March 5, 2011 A new study upends common beliefs about what makes for a long life. Two Proteins Play Key Roles in Burkitt's Lymphoma March 4, 2011 A new study from the Sbarro Health Research Organization reveals new molecular insights into the understanding and treatment of Burkitt`s lymphoma. New Study Finds Molecular Mechanisms that Control Rb2/p130 Gene Expression in Lung Cancer February 24, 2011 New findings from SHRO reveal why the Rb2/p130 gene is expressed differently in small and non-small lung cancer cells. February 16, 2011 Do we expect scientists always to be right? And have these expectations, along with a need to publish and be funded, led to an epidemic of problems with medical research? An insightful article, Lies, Damned Lies, and Medical Science examines these pressing issues. Proposed NIH Budget Cuts Go Deep February 9, 2011 House Appropriations Chairman Hal Rogers announced a partial list of 70 spending cuts that
will be included in an upcoming Continuing Resolution (CR) Bill that covers the remainder of government spending for fiscal
year (FY) 2011. Cell Cycle Regulators/Inhibitors & Cancer January 12, 2011 International Conference, Feb. 5-8, 2011, Vienna For more information go toCnference SHRO RELEASE 2010 SHRO Supports The Lancet's Case Against Canadian Asbestos December 10, 2010 Dr. Antonio Giordano, the director of the Sbarro Institute for Cancer Research and Molecular
Medicine and Chairman of the Scientific Advisory Committee for the Human Health Foundation, a nonprofit biomedical research
foundation in Italy, has voiced deep concerns about the actions of the Canadian government for its support of the asbestos industry. Dr. Giordano Awarded Honorary Professorship December 7, 2010 The Autonomous University of Santo Domingo (UASD) has named Dr. Antonio Giordano, the Director of the Sbarro Institute for Cancer Research and Molecular Medicine, as an Honorary Professor in the Faculty of Health Sciences for his valuable contributions to research and the development of biomedicine. Single Shot of Morphine Shows Long Lasting Effect on Testosterone Levels November 9, 2010 A single injection of morphine to fight persistent pain in male rats strongly reduces the hormone testosterone in the brain and plasma, according to a new paper published in Molecular Pain. The study was led by Anna Maria Aloisi, M.D., of the Department of Physiology – Section of Neuroscience and Applied Physiology at the University of Siena, Italy, in collaboration with the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia and the University of Siena, and the Human Health Foundation in Spoleto, Italy. Inaugural Award for Ethics and Medical Creativity October 20, 2010 On October 22nd, the Giovan Giacomo Giordano Foundation and the National Italian American Foundation (NIAF)(www.niaf.org) will jointly present the first Award for Ethics and Medical Creativity to Senator Prof. Ignazio R. Marino at the NIAF 35th anniversary gala at the Washington Hilton in Washington, D.C.The award honors the memory of Prof. Giovan Giacomo Giordano, a distinguished Italian medical oncologist and pathologist who devoted over 60 years of his life to the fields of cancer research and teaching. Metabolic syndrome affects breast cancer risk in postmenopausal women October 18, 2010 Metabolic syndrome may be an indicator of breast cancer risk in post-menopausal women, according to a new study published by CROM (The Cancer Research Center in Mercogliano, Italy), the National Cancer Institute of Naples, Italy, and the Sbarro Health Research Organization, located at Temple University in Philadelphia, PA and at the University of Siena in Siena, Italy. Lead authors of the study were Immacolata Capasso, M.D. and Emanuela Esposito, M.D. both of the Department of Senology at the National Institute of Naples and Antonio Giordano, M.D., Ph.D., Director of the Sbarro Institute for Cancer Research and Molecular Medicine at the College of Science and Technology at Temple University in Philadelphia, PA. Results of the study are online and will be published in the December issue of Cancer Biology and Therapy. Let's Talk About It! A Panel Discussion on Breast Cancer Awareness October 9, 2010 Join NIAF and the Sbarro Health Research Organization for a panel discussion on breast cancer on October 22nd during the 35th Gala of the National Italian American Foundation. Panelists include Dr. Antonio Giordano, Director of the Sbarro Institute for Molecular Medicine and Center for Biotechnology; Dr. Silvia Formenti, Chairman, NYU Dept. of Radiology; and Sen, Ignazio Marino, Investigative Committee on the National Healthcare System(Italian Senate). Breaking Ground for SHRO Wing for International Students and Researchers October 5, 2010 On Friday, October 1, groundbreaking ceremonies were held for the new Beech International Apartments at Temple University, which will house the Sbarro Health Research Organization wing for international students and researchers. Prestigious Award to Antonio Giordano October 4, 2010 Antonio Giordano, M.D., Ph.D., Director of the Sbarro Institute for Cancer Research and Molecular Medicine and the Center for Biotechnology, was awarded the title of Commendatore, or Knight Commander, by the Republic of Italy on October 1st. The award was given for his important findings in cancer research. The awards are bestowed on "exemplary citizens who have shown respect for civic values and their work in the interest of common development. New Research Holds Promise for Treating Breast Cancer September 26, 2010 Leptin may reduce the cytotoxicity of cAMP elevating agents and lead to new treatments for breast cancer. An interview with Dr. Silvio Naviglio of the Second University of Naples. Promising New BioTherapy Against Melanoma September 16, 2010 SHRO Scientific Advisory Board Member Michele Maio announces trials for promising new cancer treatment Top 20 Papers in Molecular Cancer -- SHRO Paper Makes the List September 7, 2010 R-Roscovitine (Seliciclib) prevents DNA damage-induced cyclin A1 upregulation and hinders non-homologous end-joining (NHEJ) DNA repair Heart Attacks Jump in Young Italian Women August 31, 2010 The incidence of acute myocardial infarction in Italy sharply increased, particularly among young women, between the years 2001 and 2005, according to a comprehensive study funded by the Human Health Foundation (HHF), a nonprofit Italian charity for biomedical research and health education in Spoleto, Italy. Aging Clinical Experimental Research Eureka Alert SHRO Researchers Interviewed on Fast Breaking paper by ScienceWatch.com August 19, 2010 Cover Article on Cell Cycle Kinases by Silvia Lapenna & Antonio Giordano Draws High Citations and Recognition from Thomson-Reuters 'Big Ride' in Philly Benefits SHRO August 10, 2010 August 2, 2010 Hospitals and patients wrestle over tumor tissue procurement, reports The Philadelphia Inquirer. Increases in Leptin May Promote Colorectal Cancer July 19, 2010 A Sbarro Institute and Istituto Superiore di Sanita, Rome, Italy study published in Endrocrine-Related Cancer shows that an increase in leptin, a cytokine that is normally increased in obese or overweight individuals, may promote colorectal neoplasms by activating colorectal cancer stem cells. July 2, 2010 Lifetime of Achievement Award Given to Dr. Giulio Tarro June 21, 2010 Distinguished clinician-researcher honored by SHRO for discoveries and service to community. New Human Health Foundation Lab Opens June 7, 2010 The Human Health Foundation (HHF), a nonprofit organization founded in 2006 to develop and fund biomedical research in Italy opened its first bioscience laboratory for the investigation of breast, brain and lung cancer on June 7th in Terni, Italy. Provenge Approved for Advanced Prostate Cancer May 30, 2010 The U.S. Food and Drug Administration has approved Provenge (sipuleucel-T), a new therapy for certain men with advanced prostate cancer that uses their own immune system to fight the disease. Understanding the Pathways to Cancer May 30, 2010 The complex mechanisms and pathways behind genetic and epigenetic changes underpin the work of Marcella Macaluso, Ph.D., a research associate professor and Director of the Genetics & Epigenetics Program at the Sbarro Health Research Organization Center for Biotechnology Sbarro Institute Joins Conference on HPV May 25, 2010 Naples conference to discuss prevention of HPV-related diseases April 27, 2010 Eva Surmacz, Ph.D., associate professor in Biology at Temple University and the Director of the Obesity and Cancer Program at SHRO studies how the cytokine leptin can cause cancer and interfere with anti-cancer therapies. Study: High fat Diet Ups Strokes in Postmenopausal Women April 27, 2010 Post-menopausal women who consume the most daily dietary fat had a 40 percent higher incidence of strokes compared with women who ate the least amount, according to research presented at the American Stroke Association International Stroke Conference 2010. New Pyrimidine Compounds May Lead to Improved Treatments for Childhood Brain Cancer April 7, 2010 Src represents one of the most promising targets for cancer therapy. A new study by researchers from the Sbarro Health Research Center for Biotechnology and the Human Health Foundation (www.hhfonlus.org), shows that pyrazolo-[3,4-d]–pyrimidine-derivatives, designed to target Src, may be effective in interfering with the cell cycle and causing cancer cell death in medulloblastoma, a childhood brain cancer. The results were published in FASEB (The Journal of the Federation of American Societies for Experimental Biology). March 22, 2010 New online forum puts pain treatment in the spotlight. Novel Researcher: Luca D'Agostino March 22, 2010 Investigating Novel Structure Proteins (NSPs) to locate new targets for cancer therapies Cutting Gravity May Speed Healing February 18, 2010 Altering gravitational forces may speed the growth and repair of tissues at the cellular level, according to research completed by Andrew Puca, Ph.D., of the Sbarro Health Research Organization Center for Biotechnology Research. Can Virtual Reality Help You to Shed Pounds? February 17, 2010 A new study funded by the College of Health Professions and Social Work Interdisciplinary Research Fund at Temple University will pair the biotechnology skills of Dr. Giuseppe Russo, a research assistant professor and director of e-Health and Cancer Systems Biology programs at the Sbarro Health Research Organization Center for Biotechnology Research in the College of Science & Technology and the weight loss expertise of Dr. Melissa Napolitano, an associate professor at the Center for Obesity Research and Education (CORE) and Departments of Kinesiology and Public Health to find out. Chronic Dry Eyes Can Be Helped February 5, 2010 Dr. Mina Massaro-Giordano, an associate professor at the University of Pennsylvania and co-director of the Penn Dry Eye & Ocular Center, explains the problem of dry eyes and the newest therapies.. Why do Stem Cells Age? New study sheds light on senescence process January 22, 2010 Researchers from the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia and the Human Health Foundation in Spoleto, Italy have found that MECP2, a gene that modifies the chromatin in the cell, has important role in stem cell aging. Changes in tumor suppressor gene suggest a heritable susceptibility to retinoblastoma January 20, 2010 Researchers working at the Sbarro Institute for Cancer Research and Molecular Medicine at Temple University in Philadelphia, PA and at the University of Siena in Siena, Italy, have found that the downregulation, or reduction, of the tumor suppressor gene 16INK4A may be a novel marker of the heritable susceptibility for the disease. The study appears in the Journal of Cellular Physiology. January is Glaucoma Awareness Month: Have You Scheduled an Eye Exam? January 20, 2010 Glaucoma, a group of eye diseases that damage the optic nerve and destroy eyesight, affects close to four million Americans, although half are not aware that they have it. Worldwide, the World Health Organization reports that glaucoma is the primary cause of blindness for about 4.5 million people With its painless and gradual loss of vision, glaucoma may have no early warning signs, but it can be detected during a comprehensive dilated eye exam. SHRO RELEASE 2009 Tracking the H1NI Pandemic in Italy November 20, 2009 According to the Italian news agency ANSA, as of November 19th, 75 Italians have died from H1N1, with 28 from the Campania region of Naples.Giulio Tarro, M.D., the Chief Physician of Virology at Cotugno Hospital of Naples and an adjunct professor at Temple University of Philadelphia discusses the impact, treatment and future of the flu epidemic. SHRO Research on Stem Cells Recognized November 20, 2009 Research by Umberto Galderisi and Antonio Giordano on the effect of stem cells in the treatment of arterial stenosis will be published as part of the proceedings of the prestigious 5th International Conference on Mesenchymal and Non-Hematopoietic Stem Cells (MSCs) at Texas A & M Health Science Center College of Medicine.
Antonio Giordano Receives Dean's Distinguished Award for Excellence in Research November 15, 2009 The award cites the quality of his work, "attested to by the fact that it provides an impetus for other investigators studying cancer growth control and it has resulted in a framework for our conceptualization of cancer development and mechanisms of tumor suppression."
Ang Sun, Ph.D. Wins Prize for 'Outstanding Research' November 3, 2009 Dr. Ang Sun, who studied for six years for his Ph.D. under the guidance of Antonio Giordano, M.D., Ph.D., the Founder and President of the Sbarro Health Research Organization, has been awarded the 2009 Award for Outstanding Research by a Graduate Student from the College of Science and Technology at Temple University. Sbarro Health Research Organization Welcomes New Biotech Research Center October 27, 2009 The Sbarro Health Research Organization, a nonprofit research facility located at Temple University, dedicated a new state-of-the-art biotechnology research center on October 27th. SHRO has been ranked as one of the top three international laboratories based on number of publications as ranked by the Cell Cycle Registry. Newswise
Dedication Planned for New SHRO Biotechnology Research Center October 18, 2009 The Sbarro Health Research Organization,will dedicate a new state-of-the-art biotechnology research center on Tuesday, October 27th, at 2 p.m. A host of dignitaries will join guests and researchers at the dedication ceremony, including Pennsylvania Representatives the Honorable Sam Smith and Mario J. Civera , Jr. Also in attendance will be His Eminence Cardinal Justin Rigali, Archbishop of Philadelphia, Ann Weaver Hart, the President of Temple University, and Hai-Lung Dai, Ph.D., the Dean of Temple University’s College of Science and Technology. Cold Spring Harbor Laboratory Celebrates Another Nobel Laureate October 5, 2009 CSHL graduate Antonio Giordano remembers Carol Greider, 2009 Nobel Prize Winner in Medicine. "National Mesothelioma Awareness Day" Introduced in Congress October 2, 2009 Few Americans know the truth about mesothelioma, a deadly and incurable cancer cauesd by exposure to asbestos. Heavy and widespread use of asbestos through most of the last century, coupled with a 20-50 year latency in tumor development, make mesothelioma today a lethal threat to tens of millions of Americans. Yet, the U.S. has ignored the need for research to develop effective treaments, and still has not even banned asbestos. Antonio Giordano and SHRO Model Profiled in Canadian Newspaper: Corriere Canadese September 27, 2009 Antonio Giordano Wins Philip Mazzei 'The Bridge ' Award September 24, 2009 President and Founder of SHRO receives the prestigious prize from The American University of Rome, in recognition of his work to promote economic and scientific cooperation between Italy and the United States.
August 28, 2009 Bidding starts at $25,000 (it's tax-deductible!) to get Your Name (or your loved one's or your company's) on a fellowship to be awarded by the Philadelphia and Siena Italy-based Sbarro Health Research Organization. Place your bid on E-Bay by clicking here ! Summer Brings High School Interns to the Sbarro Institute August 18, 2009 If it is summer in the city, that means that high school interns are hard at work in the Sbarro Institute laboratories located at Temple University in Philadelphia. This year, the Institute hosted three high school juniors, who worked closely with Sbarro Institute post-doctorate fellows Marco Cassone, M.D., Ph.D. and Valentina Caracciolo, Ph.D. and Annalisa Roberti, a Ph.D student. Antonio Giordano, M.D., Ph.D.: A War We Must Win Neuronal Guidance Molecule May Lead to Future Treatments for Human Embryonal Carcinoma Students Visit SHROs Digilab: Cell Cycle Kinases as Therapeutic Targets for Cancer: Antonio Giordano, M.D., Ph.D. Places Third on List of "Laboratory Heads by Number of Publications"
Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported: June 29, 2009 Italy Welcomes New Public Health TV Channel Researchers Locate Two New Potential Targets for Pediatric Tumor Treatments Gene Marker May Improve Odds on Stem Cell Therapies for Disease With an Eye To Italy SHRO RELEASE 2008 International Conference Hosts Digi S Lab Sbarro Health Research Organization researcher Dr. Letizia Cito of the CROM Institute, Mercogliano (AV, Italy) delivered a virtual lecture on "Cancer, Cell Cycle, and Check Points" as an invited guest to a scientific meeting sponsored by the University of Barcelona, Spain. Dr. Cito's lecture took place on The Learning Experience Main Campus in Second Life. View the lectures: Part-1 Part-2 Discovery of Small Molecule Leads to New Hope for HIV Therapy New hope for combating HIV, the virus that leads to AIDS. The Laboratory of Pharmaceutical Chemistry, University of Siena, led by Professor Maurizio Botta, an Adjunct Professor at SHRO, took part to this research. Nature Clinical Practice Cardiovascular Medicine: September, 2008, Vol.8, No.9 Stem cell niches as clinical targets: the future of anti-ischemic therapy? Editorial on possible clinical impact of research conducted by an international collaboration of scientists directed by Sbarro Institute Professor Claudio Napoli, M.D., Ph.D. Sbarro Institute Professor Claudio Napoli, M.D., Ph.D. Directs International Collaboration on Therapeutic Targeting of the Stem Cell Niche in Experimental Hindlimb Ischemia published in Nature Clinical Practice Cardiovascular Medicine CNN I-Report Blog: August 14, 2008 Report on tour of Biomedical Research Labs Island in the company of Prof. Giuseppe Russo (sl name Alfa Roux) , the owner of the sim and CEO of Digi S Lab SHRO Scores on Second Life: Linden Labs Cites SHRO Platform as Model for Other Health and Wellness Nonprofit Organizations NewsWise| CNN Blog: Jan 11, 2008 SHRO Opens Internet Center on Futuristic Second Life
SHRO Release: October 21, 2008 Developmental Biologist Gianfranco Bellipanni, Ph.D. Joins Faculty of the Sbarro Intstitute.
International Team Reveals First Prognosticator of Survival in Aggressive
Cancer Summer Science at Sbarro Institute: International program mentors college
and high school students for 15th year
Anna Rita Fioroni, Senator of the Democratic Party (PD) in Italy, recently paid a visit to the Sbarro Health
Research Organization (SHRO) in Philadelphia
SHRO Release
SHRO Fellow Mario Federico, M.D., publishes chapter on brachytherapy in Principles and Practice of
Radiation Oncology, the most widely used textbook on radiation oncology. SHRO Release | NewsWise: June 25, 2008 Protein Cdk9-55 May Induce Muscle Regeneration in Damaged and Healthy Tissues Journal of Cellular Physiology: June 10, 2008 Cdk9-55: A New Player in Muscle Regeneration Professor Claudio Napoli: Novel Approach May Spell Safer Gene Therapy
SHRO Release: Jan 11, 2008 SHRO RELEASE 2007 SHRO RELEASE 2006 SHRO RELEASE 2005 |
||||||
TOP | CONTACT | SALUTE-PRESS | DONATE | LINKS |
|
© Copyright 2003 - 2010, Sbarro Health Research Organization,All rights reserved. |